G

    Guardian Pharmacy Services, Inc. (GRDN)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $37.10
    +0.04 (+0.11%)

    Market Cap: $2.35B

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    88%(7/8)
    Avg Surprise
    +14.30%
    Streak
    5 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.32
    Range$0.29 - $0.33
    6 analysts
    EPS Revisions
    4
    0
    7d
    4
    0
    30d
    EPS Estimate Drift
    90d ago$0.30-4.2%
    60d ago$0.30-4.2%
    30d ago$0.30-4.2%
    7d ago$0.30-4.2%
    Current$0.32
    Revenue Consensus
    $366M
    Range$363M - $369M
    6 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.49
    Range$0.43 - $0.52
    6 analysts
    Revenue Consensus
    $405M
    Range$399M - $410M
    6 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.49---
    Sep 26EST
    		-$0.32---
    Jun 26
    Reported Aug 6
    		$0.24$0.24+0.00%Beat+9.1%
    Mar 26
    Reported May 6
    		$0.29$0.24+20.83%Beat+38.1%
    Dec 25
    Reported Mar 11
    		$0.37$0.27+38.32%Beat+55.4%
    Sep 25
    Reported Nov 10
    		$0.25$0.24+4.17%Beat-10.7%
    Jun 25
    Reported Aug 11
    		$0.22$0.22+0.00%Beat-10.2%
    Mar 25
    Reported May 12
    		$0.21$0.22-4.55%Miss-
    Dec 24
    Reported Mar 26
    		$0.24$0.22+8.23%Beat-
    Sep 24
    Reported Nov 12
    		$0.28$0.19+47.37%Beat-
    Jun 24
    Reported Aug 22
    		$0.24$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio32.26EV/EBITDA19.28x
    Price/FCF31.21xFCF Yield3.20%
    Profitability
    Profit Margin4.50%Operating Margin3.48%
    ROE30.40%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage152.85x
    Current Ratio1.65xQuick Ratio1.33x
    Trading Statistics
    BetaN/AAvg Volume363.01K
    52-Week High$47.0252-Week Low$23.14

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$37.56
    SMA 20$38.72
    SMA 50$39.84
    SMA 200$35.58
    EMA 10$37.66
    EMA 20$38.38
    EMA 50$39.15
    EMA 200$35.63

    MACD

    Line: -0.86Signal: -0.74Hist: -0.13

    ADX

    ADX: 6.4+DI: 18.9-DI: 21.3

    Aroon & PSAR

    Aroon Up36.0
    Aroon Down100.0
    PSAR$38.90

    Bollinger Bands

    Upper Band$42.17
    Lower Band$35.26
    %B Position1785%(Upper)
    Band Width0.27

    RSI (14-Day)

    Neutral
    39.4

    Momentum Oscillators

    Stoch %K8.8
    Stoch %D7.2
    Williams %R-86.6
    ROC (10d)-2.4%
    Momentum-0.90
    CCI (20d)-84.6
    MFI (14d)36.1

    Volatility Measures

    ATR (14d)$1.50(4.0%)
    StdDev (20d)1.73
    Hist Vol50.3%(High)

    Volume Flow

    VWAP$37.06
    OBV7.9M
    AD Line3.5M
    CMF (20d)-0.288

    Volume Metrics

    Avg Vol (20d)368.8K
    Vol Ratio0.8x
    VWMA (20d)$39.25

    Pivot Points

    R3$38.27
    R2$37.94
    R1$37.50
    Pivot Point$37.17
    S1$36.73
    S2$36.40
    S3$35.96

    Advanced Oscillators

    TSI-16.35
    Ultimate Osc45.9
    KST-72.56

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$351.77M$336.60M$397.62M$377.43M$344.33M$329.31M$338.57M$314.39M$300.04M$275.41M$281.07M$262.74M
    Cost of Revenue$271.72M$260.29M$312.11M$302.71M$276.19M$264.96M$271.46M$253.51M$238.75M$220.31M$226.49M$210.55M
    Gross Profit$80.04M$76.31M$85.50M$74.72M$68.15M$64.35M$67.10M$60.88M$61.29M$55.10M$54.58M$52.19M
    Operating Expenses$59.40M$58.63M$54.74M$58.37M$55.57M$51.34M$50.35M$165.49M$44.28M$47.17M$39.05M$58.52M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$59.40M$58.63M$54.74M$58.37M$55.57M$51.34M$50.35M$165.49M$44.28M$47.17M$12.22M$58.52M
    Operating Income$20.64M$17.68M$30.76M$16.35M$12.58M$13.01M$16.75M$-104,613,000$17.00M$7.93M$15.52M$-6,330,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$154,000$154,000$163,000$160,000$172,000$170,000$421,000$1.03M$1.07M$765,000$739,000$716,000
    Income Before Tax$29.79M$18.29M$31.10M$16.63M$12.59M$13.11M$16.22M$-105,641,000$15.85M$7.09M$14.56M$-6,995,000
    Income Tax Expense$7.67M$4.75M$9.83M$7.04M$3.76M$3.83M$4.38M$176,000$0$0$0$0
    Net Income$22.12M$13.54M$21.27M$9.59M$8.83M$9.27M$11.84M$-105,817,000$15.85M$7.09M$12.02M$-6,995,000
    EBITDA$35.75M$24.42M$37.00M$22.63M$18.25M$18.54M$21.80M$-99,621,000$21.79M$12.61M$20.01M$-6,279,000
    EBIT$29.95M$18.45M$31.26M$16.79M$12.76M$13.28M$16.64M$-104,615,000$16.91M$7.86M$15.30M$-6,279,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about GRDN

    News

    The Bull Case For Guardian Pharmacy Services (GRDN) Could Change Following Upbeat Q2 Results And Higher 2026 Guidance - Learn Why

    Guardian Pharmacy Services (GRDN) reported strong Q2 2026 results with increased sales and net income, leading to a raised full-year 2026 revenue guidance of US$1.43–1.45 billion. This positive performance reinforces the investment narrative centered on growth from an aging population, despite ongoing risks from Medicare Part D and Inflation Reduction Act changes. The company's future revenue and earnings projections suggest a fair value of $47.00, indicating a 24% upside from its current price.

    Simply Wall Street•8/20/26•
    Bullish

    The Bull Case For Guardian Pharmacy Services (GRDN) Could Change Following Upbeat Q2 Results And Higher 2026 Guidance - Learn Why

    Guardian Pharmacy Services reported strong Q2 2026 results with increased sales and net income, alongside a raised full-year 2026 revenue guidance to US$1.43–1.45 billion. This positive financial update supports the company's growth narrative, but investors should still consider potential risks from Medicare Part D and Inflation Reduction Act changes. The article suggests exploring other perspectives on GRDN's fair value and overall financial health.

    Simply Wall Street•8/20/26•
    Bullish

    Guardian Pharmacy CEO to join a Sept. 15 fireside chat for investors

    Guardian Pharmacy Services, Inc. (NYSE: GRDN) announced that its President and CEO, Fred Burke, will participate in a fireside chat at the Jefferies Healthcare Services Conference on September 15, 2026. The event, starting at 2:25 p.m. CST, will be accessible via a live audio webcast on the company's investor relations website. Guardian Pharmacy Services specializes in long-term care pharmacy services, operating a network of over 61 pharmacies serving approximately 210,000 residents.

    Stock Titan•8/19/26•
    Neutral

    Guardian Pharmacy Services, Inc., to Participate in Upcoming Jefferies Healthcare Services Investor Conference

    Guardian Pharmacy Services, Inc. (NYSE: GRDN) announced its participation in the Jefferies Healthcare Services Conference on September 15, 2026. President and CEO Fred Burke will lead a fireside chat, which will be webcast live on the company's investor relations website. The company, a leading long-term care pharmacy services provider, serves approximately 210,000 residents through its network of over 61 licensed pharmacies.

    FinancialContent•8/19/26•
    Somewhat-Bullish

    Guardian Pharmacy Services opens first location in Kentucky

    Guardian Pharmacy Services has opened its first Kentucky location, Guardian Pharmacy of Kentucky, in Lexington. This new long-term care pharmacy will serve residents in various care settings across the state. The expansion aims to meet increasing demand for LTC pharmacy services in Kentucky, combining local leadership with centralized corporate support.

    McKnight's Senior Living•8/13/26•
    Bullish

    Frequently Asked Questions About GRDN

    Does GRDN pay dividends?
    Guardian Pharmacy Services, Inc. (GRDN) does not currently pay a regular dividend.
    What is GRDN's P/E ratio?
    Guardian Pharmacy Services, Inc. has a price-to-earnings (P/E) ratio of 32.26.
    What is GRDN's market cap?
    Guardian Pharmacy Services, Inc. (GRDN) has a market capitalization of $2.35B with a current stock price of $37.10.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In